I2I
NAGE

Insight 2811 Inc’s Niagen Bioscience NAGE Stock Holding History

Insight 2811 Inc’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.8K Hold
22,834
– – 0.03% 108
2026
Q1 		$101K Hold
22,834
– – 0.04% 100
2025
Q4 		$145K Buy
+22,834
New +$159K 0.06% 97
2020
Q3 		– Sell
-31,502
Closed -$158K – 72
2020
Q2 		$158K Buy
31,502
+19,412
+161% +$86.9K 0.1% 58
2020
Q1 		$39K Hold
12,090
– – 0.03% 65
2019
Q4 		$52K Buy
+12,090
New +$43K 0.03% 93

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Insight 2811 Inc's NAGE Position: Q2 2026 in Review

Insight 2811 Inc held its Niagen Bioscience (NAGE) position steady in Q2 2026 at 22,834 shares worth $72.8K. The position accounts for 0.03% of the portfolio, ranked #108.

Insight 2811 Inc first reported a position in NAGE in Q4 2019 and has held it in 6 quarters since. The position peaked at $158K in Q2 2020. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Insight 2811 Inc held 22,834 shares of Niagen Bioscience worth $72.8K as of Q2 2026.
  • Insight 2811 Inc left its Niagen Bioscience share count unchanged in Q2 2026.
  • Niagen Bioscience made up 0.03% of Insight 2811 Inc's portfolio in Q2 2026, its #108 holding.
  • Insight 2811 Inc first reported a position in Niagen Bioscience in Q4 2019 and has held it in 6 quarters since.
  • Insight 2811 Inc's Niagen Bioscience position peaked at $158K in Q2 2020.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Insight 2811 Inc's 13F filing for Q2 2026, filed 11 Aug 2026.